Adrestia

Babraham, United Kingdom Founded: 2018 • Age: 8 yrs Acquired By Insmed
Pharmaceutical drugs for multiple therapeutic areas are manufactured.
Annual revenue - Latest available
Total funding - 1 rounds
Employees - Tracked headcount
Investors 3 Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Adrestia

Adrestia is a company based in Babraham (United Kingdom) founded in 2018 was acquired by Insmed in July 2023. Adrestia offers products and services including Potatoes and Grain Marketing.

  • Headquarter Babraham, United Kingdom
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Maine Potato Growers, Inc
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
    Insmed

    & 2 more

  • Employee Count
    Employee Count
  • Acquired by
    Insmed

    (Jul 17, 2023)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Adrestia

Adrestia offers a comprehensive portfolio of products and services, including Potatoes and Grain Marketing.

Primary

Potatoes are farmed and sold for food and industrial purposes.

Grains are promoted and distributed from various farms.

People of Adrestia

Headcount 10-50
Employee Profiles 20
Employee Profiles
People
Flavius Alecsa
Scientist
People
John Perry
Vice President of Human Genetics
People
Jane Whitrow
Interim Chief Operations Officer
People
Jennifer Millian
Vice President US Operations

Unlock access to complete

Funding Insights of Adrestia

  • Total Funding
  • Total Rounds 1
  • Last Round
  • First Round
  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2020 Amount Series A - Adrestia Valuation GSK , Ahren

Investors in Adrestia

Adrestia has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Insmed, GSK and Ahren Innovation Capital.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Investment in deep technology and science is facilitated.
Founded Year Domain Location
Developer of pharmaceuticals and vaccines for various therapeutic areas
Founded Year Domain Location
Developer of small molecule inhibitors for rare lung diseases
Founded Year Domain Location

Investments & Acquisitions by Adrestia

Investments

Financial Statements - Adrestia

Adrestia Comparisons

+
Add Comparison
Available on Premium

Competitors of Adrestia

Latest news on Adrestia

Frequently Asked Questions about Adrestia

Adrestia was founded in 2018 and raised its 1st funding round 2 years after it was founded.

Adrestia is headquartered in Babraham, United Kingdom. It is registered at Babraham, Cambridgeshire, United Kingdom.

Will Lewis is the current CEO of Adrestia.

Adrestia was founded in 2018 and is based in Babraham, United Kingdom. Operations are centered on the manufacturing of drugs across various therapeutic areas within the pharmaceutical sector. Focus is placed on producing medications to address diverse medical needs. The company is led by CEO Will Lewis, with activities conducted from its UK location to support global health applications.

Adrestia offers Potatoes and Grain Marketing.

Adrestia has 3 investors. Key investors include Insmed, GSK, and Ahren Innovation Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available